Biotechnology

MEDTEC China South 2016 to Open in Shenzhen on March 16

SHENZHEN, China, March 15, 2016 /PRNewswire/ -- MEDTEC China South, the world's leading medical design & manufacturing exhibition and conference will be holding inShenzhen to serve the medical device industry in Southern China, and the show will open from 16-17th March, at the Shenzhen Great Chin...

2016-03-15 13:05 2206

DERMALOG Provides Fingerprint Scanners for Refugee Registration in Germany

HANOVER, Germany, March 12, 2016 /PRNewswire/ -- - Cross reference: Picture is available at AP Images (http://www.apimages.com ) - DERMALOG, the leading innovator in biometric solutions, supplies the new fingerprint scanners for refugee registration in Germany. The LF1...

2016-03-12 03:19 3489

3SBio's PEG-irinotecan Wins IND Approval From China FDA

SHENYANG, China, March 7, 2016 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology company based inChina focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has received an Investigational New Drug ("IND") approval letter ...

2016-03-07 17:24 2651

3SBio Inc. Announces Expansion of its Leadership Team

SHENYANG, China, March 4, 2016 /PRNewswire/ -- 3SBio Inc. (Hong Kong: 1530)  ("3SBio" and together with its subsidiaries the "3SBio Group") is pleased to announce thatKevin Xiao Weihong has joined 3SBio as its new chief operating officer. "We are pleased to welcome Kevin to 3SBio where he will p...

2016-03-04 19:03 3423

Nanotechnology Accelerates the Evolution of Precision Medicine, Finds Frost & Sullivan

BUENOS AIRES, Argentina, March 2, 2016 /PRNewswire/ -- The remarkable progress made in medicine and wellness over the last ten years is partially due to the radical advances made in nanotechnology. This technology's core healthcare applications include nanomedicine, nanobiosensing, nano self-asse...

2016-03-02 03:28 2391

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016

HONG KONG, March 1, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial...

2016-03-01 05:16 1841

Veritas Genetics and WorldCare Partnership First to Integrate Next Generation Whole Genome Sequencing and World-Class Medical Second Opinion Services

BOSTON, Feb. 24, 2016 /PRNewswire/ -- Veritas Genetics and WorldCare today announce a strategic partnership to integrate their next generation genetic testing with world-class medical second opinion services provided by the WorldCare Consortium®. This global partnership bridges the gap between ge...

2016-02-24 08:00 2143

Value Based Healthcare Transformation Spurs Innovative Opportunities for Industry Participants

MOUNTAIN VIEW, Calif., Feb. 23, 2016 /PRNewswire/ -- With Artificial Intelligence (AI) enabling a vast array of applications, healthcare companies have been eager to layer their existing lines of business with AI-based services. While pharma companies have been seeking tools for tracking the eff...

2016-02-23 22:35 1640

Aptuit and Icagen Agree to Strategic Alliance

GREENWICH, Conn., Feb. 22, 2016 /PRNewswire/ -- Aptuit LLC and Icagen, Inc. today announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services. (Logo: http://photos.prnewswire.com/prnh/20150709/234432LOGO

2016-02-22 22:00 1699

China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results

HONG KONG, Feb. 22, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months of fiscal year 2016 onMonday, February 29, 2016, after market close.  The Company will host a c...

2016-02-22 20:00 1860

Micreos Secures EUR12 Million for New Products Containing Staphefekt; Alternative to Antibiotics Can Help Millions

THE HAGUE, The Netherlands, Feb. 18, 2016 /PRNewswire/ -- Dutch biotech company Micreos announces today that it has secured €12 million in additional equity for the global development of its antibacterial lysin technology, Staphefekt in new products. Micreos intends to use the secured funds, whic...

2016-02-18 20:00 2622

Announcing the QA-ES III Electrosurgical Analyzer for testing and ensuring the proper performance and safety of electrosurgical units

EVERETT, Washington, Feb. 16, 2016 /PRNewswire/ -- An electrosurgical unit (ESU) that does not function correctly can be hazardous, leading to ineffective cutting, cauterizing, or vessel sealing, burning a patient or physician, or even starting a fire. It is, therefore, important to verify the pe...

2016-02-16 06:00 2440

Jubilant Biosys and Sanofi Deutschland GmbH Enter Into a Strategic Alliance Focusing on Metabolic Disorders Therapeutic Area

BENGALURU, Jan. 7, 2016 /PRNewswire/ -- Collaboration Aimed at Discovery and Development of Small Molecule Inhibitors  Through to Phase I Proof of Mechanism in Metabolic Disorders Therapeutic Area   Jubilant Biosys Ltd , a Bengaluru-based subsidiary of Jubilant Life S...

2016-01-07 22:48 2570

Merck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing

DARMSTADT, Germany, Jan. 7, 2016 /PRNewswire/ -- * Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing  * Collaboration allows Merck to provide complementary molecular testing solutions to various laboratory segments  ...

2016-01-07 16:41 2802

BioAtla And Sinobioway Select First Programs For Strategic Collaboration In China Market

SAN DIEGO, Jan. 6, 2016 /PRNewswire/ -- BioAtla LLC, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that BioAtla and Beijing Sinobioway Group Company, Limited (Sinobioway) selected their first product program...

2016-01-06 11:20 2663

Lixte Biotechnology Holdings, Inc. Announces Exclusive Licensing Of Their Lead Anti-Cancer Compound LB-100 For Potential Treatment Of Hepatocellular Carcinoma In Asia To Taipei Medical University

EAST SETAUKET, N.Y., Jan. 5, 2016 /PRNewswire/ -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced last week that it has granted an exclusive license of its lead anti-cancer compound, LB-100, for treatment of hepatocellular carcinoma (HCC) inAsia to Taipei Medical University (TMU). LB-1...

2016-01-05 09:06 1997

Increased Investment Spurs Advances in Gene Therapy

MOUNTAIN VIEW, Calif., Dec. 17, 2015 /PRNewswire/ --  Currently, gene therapy is recovering across the biopharmaceutical industry as the quality and effectiveness of the technology shows gradual, but marked improvement. While safety concerns during the nascent phases affected technology adoption,...

2015-12-17 22:35 2091

Cathay Industrial Biotech, Ltd Announces $135M in New Financing for Monomer and Bio-Polyamide Expansion

SHANGHAI, Dec. 14, 2015 /PRNewswire/ -- Cathay Industrial Biotech, Ltd. (Cathay), a leading privately-held industrial biotechnology company focused on producing specialty bio-based chemicals, announced a new round of financing which will be used for additional production capacity at their existin...

2015-12-14 18:48 8186

China Cord Blood Corporation Announces Results of 2015 Annual General Meeting

HONG KONG, Dec. 10, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2015 Annual Gene...

2015-12-10 22:00 2600

Avantium Reserves Capacity in its First FDCA Production Plant for Mitsui

TOKYO, Dec. 10, 2015 /PRNewswire/ -- Avantium signed an agreement with Mitsui & Co., Ltd. ('Mitsui'), to commercialize 100% biobased chemicals FDCA and PEF inAsia. As part of this agreement, Mitsui has been granted a right to purchase a sizable volume of FDCA from the first commercial FDCA p...

2015-12-10 14:00 2593
1 ... 5051525354